Budiodarone is an anti-arrhythmic drug used to treat various heart-related conditions. However, during the manufacturing process, impurities may be introduced that can affect the quality and safety of the drug. These impurities can include residual solvents, starting materials, and reaction by-products. The identification and monitoring of these impurities are crucial to ensure the efficacy and safety of the drug.